Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GanShenAn Granules in type 2 diabetes patients with liver-yin and kidney-yin deficiency
ChiCTR-TRC-14004179Phase 4Completed
- Sponsor
- Shuguang Hospital
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of GanShenAn in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Shuguang Hospital. Primary endpoint: Change in reduction score of TCM main syndrome for liver-yin and kidney-yin deficiency. Started Jan 2014; status: completed.
02
Drugs
GanShenAn
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-14004179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004179.